BOTANIX PHARMACEUTICALS LTD - News & Media

Market Cap $707.4M Add to my watchlist

Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company is... Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company is engaged in the development and commercialization of treatments for common skin diseases and infections. Its lead product is Sofpironium Bromide, for the treatment of primary axillary hyperhidrosis. It also has a pipeline of other products in late-stage clinical studies for the treatment of moderate to severe rosacea, dermatitis, and acne respectively. It also developing a topical antimicrobial product for the eradication of bacteria on the skin surface, initially in patients who are undergoing hemodialysis. Its BTX1503 product is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX1702 product for the treatment of papulopustular rosacea. Its BTX 1204A canine study in Australia and New Zealand for atopic dermatitis. Its BTX1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No News & Media currently available.

(20min delay)
Last 32.0¢		Change 0.005(1.59%)		Mkt cap ! $707.4M

Open	High	Low	Value	Volume
31.5¢	32.5¢	31.0¢	$1.169M	3.655M

Buyers (Bids)

No.	Vol.	Price($)
9	274982	31.5¢

Sellers (Offers)

Price($)	Vol.	No.
32.0¢	48600	2

View Market Depth

No.	Vol.	Price($)
11	423267	0.105
23	1189777	0.100
1	10111	0.099
1	50000	0.098
1	50000	0.097

Price($)	Vol.	No.
0.110	555657	10
0.115	560304	6
0.120	829451	14
0.125	1083838	12
0.130	498290	12

Last trade - 16.10pm 22/11/2024 (20 minute delay)


Last 31.8¢		Change 0.005 ( 1.44 %)
Open	High	Low	Volume
31.5¢	32.3¢	31.0¢	1512263
Last updated 15.59pm 22/11/2024 ?

BOT (ASX) Chart